Advertisement

Hirntumoren

  • Torsten Pietsch
Chapter
Part of the Molekulare Medizin book series (MOLMED)

Zusammenfassung

Neoplasien des zentralen Nervensystems stellen eine heterogene Gruppe von Tumorentitäten unterschiedlichster Histogenese und biologischer Wertigkeit dar. Sie beinhaltet sowohl sehr gutartige Läsionen; häufiger sind jedoch maligne Tumoren mit zumeist ungünstiger Prognose. Im Erwachsenenalter machen die Gehirntumoren mit 2% nur einen geringen Anteil aller Tumorerkrankungen aus, im Kindes- und Jugendalter dagegen repräsentieren sie nach den Leukämien und Lymphomen die zweithäufigste Krebserkrankung. Auch das Spektrum der Tumorentitäten variiert. Während bei Erwachsenen zahlenmäßig die - zumeist bösartigen - glialen Neoplasien überwiegen, kommen im Kindes- und Jugendalter andere Entitäten gehäuft vor, so z. B. die Gruppe der embryonalen Tumoren.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B (1999) Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59:74–79PubMedGoogle Scholar
  2. Biegel JA, Fogelgren B, Zhou JY et al. (2000) Mutations of the INI1 rhabdoid tumor suppressor gene in medullo blastomas and primitive neuroectodermal tumors of the central nervous system. Clin Cancer Res 6:2759–2763PubMedGoogle Scholar
  3. Bigner DD, McLendon RE, Bruner JM (1998) Russell and Rubinstein’s pathology of tumors of the nervous system. Arnold, LondonGoogle Scholar
  4. Blumcke I, Lobach M, Wolf HK, Wiestler OD (1999) Evidence for developmental precursor lesions in epilepsy-associated glioneuronal tumors. Microsc Res Tech 46:53–58PubMedGoogle Scholar
  5. Brinster RL, Chen HY, Messing A, Dyke T van, Levine AJ, Palmiter RD (1984) Transgenic mice harboring SV40 Tantigen genes develop characteristie brain tumors. Cell 37:367–379PubMedGoogle Scholar
  6. Brown HG, Kepner JL, Perlman EJ et al. (2000) “Large cell/ anaplastie” meduHoblastomas: a Pediatric Oncology Group Study. J Neuropathol Exp Neurol 59:857–865PubMedGoogle Scholar
  7. Budka H, Chimelli L (1994) Lipomatous medulloblastoma in adults: a new tumor type with possible favorable prognosis. Hum Pathol 25:730–731PubMedGoogle Scholar
  8. Bühren J, Christoph AH, Buslei R, Albrecht S, Wiestler OD, Pietsch T (2000) Expression of the neurotrophin receptor p75NTR in medulloblastomas is correlated with distinct histological and clinical features: evidence for a medulloblastoma subtype derived from the external granule ceH layer. J Neuropathol Exp Neurol 59:229–240PubMedGoogle Scholar
  9. Camilleri-Broet S, Davi F, Feuillard J et al. (1997) AIDS-related primary brain lymphomas: histopathologic and immunohistochemical study of 51 cases. The French Study Group for HIV-Associated Tumors. Hum Pathol 28:367–374PubMedGoogle Scholar
  10. Carroll RS, Glowacka D, Dashner K, Black PM (1993) Progesterone receptor expression in meningiomas. Cancer Res 53:1312–1316PubMedGoogle Scholar
  11. Cerda-Nicolas M, Lopez-Gines C, Peydro-Olaya A, LlombartBosch A (1993) Central neurocytoma: a cytogenetic case study. Cancer Genet Cytogenet 65:173–174PubMedGoogle Scholar
  12. Cingolani A, De Luca A, Larocca LM et al. (1998) Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma. J Natl Cancer lust 90:364–369Google Scholar
  13. Cobbers JM, Wolter M, Reifenberger J et al. (1998) Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL. Brain Pathol 8:263–276PubMedGoogle Scholar
  14. Dash RC, Provenzale JM, McComb RD, Perry DA, Longee DC, McLendon RE (1999) Malignant supratentorial ganglioglioma (ganglion cell-giant cell glioblastoma): a case report and review of the literature. Arch Pathol Lab Med 123:342–345PubMedGoogle Scholar
  15. Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, Laws ER Jr, Vedrenne C (1988) Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery 23:545–556PubMedGoogle Scholar
  16. DeCristofaro MF, Betz BL, Wang W, Weissman BE (1999) Alteration of hSNF5/1NI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms’ tumors. Oncogene 18:7559–7565PubMedGoogle Scholar
  17. Deimling A von, Kleihues P, Saremaslani P et al. (1991) Histogenesis and differentiation potential of central neurocytomas. Lab Invest 64:585–591Google Scholar
  18. De Potter P, Shields CL, Shields JA (1994) Clinical variations of trilateral retinoblastoma: a report of 13 cases. J Pediatr Ophthalmol Strabismus 31:26–31PubMedGoogle Scholar
  19. Donovan MJ, Yunis EJ, DeGirolami U, Fletcher JA, Schofield DE (1994) Chromosome aberrations in choroid plexus papillomas. Genes Chromosomes Cancer 11:267–270PubMedGoogle Scholar
  20. Eberhart CG, Tihan T, Burger PC (2000) Nuclear localization and mutation of ß-catenin in medulloblastomas. J Neuropathol Exp Neurol 59:333–337PubMedGoogle Scholar
  21. Eng D.Y., DeMonte F, Ginsberg L, Fuller GN, Jaeckle K (1997) Craniospinal dissemination of central neurocytoma. Report of two cases. J Neurosurg 86:547–552Google Scholar
  22. Figarella-Branger D, Pellissier JF, Daumas-Duport C et al. (1992) Central neurocytomas. Critical evaluation of a small-cell neuronal tumor. Am J Surg Pathol 16:97–109PubMedGoogle Scholar
  23. Fung KM, Trojanowski JQ (1995) Animal models of medulloblastomas and related primitive neuroectodermal tumors. A review. J Neuropathol Exp Neurol 54:285–296PubMedGoogle Scholar
  24. Giangaspero F, Perilongo G, Fondelli MP et al. (1999) Medulloblastoma with extensive nodularity: a variant with favorable prognosis. J Neurosurg 91:971–977PubMedGoogle Scholar
  25. Gorlin RJ (1995) Nevoid basal cell carcinoma syndrome. Dermatol Clin 13:113–125PubMedGoogle Scholar
  26. Greenlee JE, Narayan O, Johnson RT, Herndon RM (1977) Induction of brain tumors in hamsters with BK virus, a human papovavirus. Lab luvest 36:636–641Google Scholar
  27. Grotzer MA, Janss AJ, Fung K et al. (2000a) TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. J Clin Oncol 18:1027–1035PubMedGoogle Scholar
  28. Grotzer MA, Janss AJ, Phillips PC, Trojanowski JQ (2000b) Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors. Klin Padiatr 212:196–199PubMedGoogle Scholar
  29. Hahn H, Wicking C, Zaphiropoulous PG et al. (1996) Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85:841–851PubMedGoogle Scholar
  30. Hamilton SR, Liu B, Parsons RE et al. (1995) The molecular basis of Turcot’s syndrome. N Engl J Med 332:839–847PubMedGoogle Scholar
  31. Harrison MJ, Wolfe DE, Lau TS, Mitnick RJ, Sachdev VP (1991) Radiation-induced meningiomas: experience at the Mount Sinai Hospital and review of the literature. J Neurosurg 75:564–574PubMedGoogle Scholar
  32. Herms J, Neidt I, Luscher B et al. (2000) C-MYC expression in medulloblastoma and its prognostic value. Int J Cancer 89:395–402PubMedGoogle Scholar
  33. Huang H, Reis R, Yonekawa Y, Lopes JM, Kleihues P, Ohgaki H (1999) Identification in human brain tumors of DNA sequences specific for SV 40 large T antigen. Brain Pathol 9:33–42PubMedGoogle Scholar
  34. Huang H, Mahler-Araujo BM, Sankila A et al. (2000) APC mutations in sporadic medulloblastomas. Am J Pathol 156:433–437PubMedCentralPubMedGoogle Scholar
  35. Ikeda J, Sawamura Y, Meir EG van (1998) Pineoblastoma presenting in familial adenomatous polyposis (FAP): random association, FAP variant or Turcot syndrome? Br J Neurosurg 12:576–578PubMedGoogle Scholar
  36. Itoyama T, Sadamori N, Tsutsumi K et al. (1994) Primary central nervous system lymphomas. Immunophenotypic, virologie, and cytogenetic findings of three patients without immune defects. Cancer 73:455–463PubMedGoogle Scholar
  37. Jay V, Edwards V, Hoving E et al. (1999) Central neurocytoma:morphological, flow cytometric, polymerase chainreaction, fluorescence in situ hybridization, and karyotypie analyses. Case report. J Neurosurg 90:348–354PubMedGoogle Scholar
  38. Jennings MT, Gelman R, Hochberg F (1985) Intracranial germ-cell tumors: natural history and pathogenesis. J Neurosurg 63:155–167PubMedGoogle Scholar
  39. Joensuu H, Roberts PJ, Sarlomo-Rikala M et al. (2001) Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Eng J Med 344:1052–1056Google Scholar
  40. Jouvet A, Saint-Pierre G, Fauchon F et al. (2000) Pineal parenchymal tumors: a correlation of histological features with prognosis in 66 cases. Brain Pathol 10:49–60PubMedGoogle Scholar
  41. Katsetos CD, Herman MM, Krishna L et al. (1995) Calbindin-D28 k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 med. Arch Pathol Lab Med 119:734–743PubMedGoogle Scholar
  42. Kees UR, Spagnolo D, Hallam LA et al. (1998) A new pineoblastoma cell line, PER-480, with der(10)t(10;17), der(16)t(1;16), and enhanced MYC expression in the absence of gene amplification. Cancer Genet Cytogenet 100: 159–164PubMedGoogle Scholar
  43. Khalili K, Krynska B, Del Valle L, Katsetos CD, Croul S (1999) Medulloblastomas and the human neurotropiepolyomavirus JC virus. Lancet 353:1152–1153PubMedGoogle Scholar
  44. Kingston RE, Bunker CA, Imbalzano AN (1996) Repression and activation by multiprotein complexes that alter chromatin structure. Genes Dev 10:905–920PubMedGoogle Scholar
  45. Kleihues P, Cavenee WK (2000) WHO classification of tumors: Pathology and genetics of tumors of the nervous system. IARC, LyonGoogle Scholar
  46. Kleihues P, Schauble B, zur Hausen A, Esteve J, Ohgaki H (1997) Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol 150:1–13PubMedCentralPubMedGoogle Scholar
  47. Kleinschmidt-DeMasters BK, Lillehei KO (1995) Radiationinduced meningioma with a 63-year latency period. Case report. J Neurosurg 82:487–488PubMedGoogle Scholar
  48. Koch A, Tonn J, Kraus JA et al. (1996) Molecular analysis of the lissencephaly gene 1 (LIS-1) in medulloblastomas. Neuropathol Appl Neurobiol 22:233–242PubMedGoogle Scholar
  49. Koch A, Waha A, Tonn JC et al. (2001) Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors. Int J Cancer 93:445–449PubMedGoogle Scholar
  50. Krynska B, Otte J, Franks R, Khalili K, Croul S (1999) Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals. Oncogene 18:39–46PubMedGoogle Scholar
  51. Lam CW, Xie J, To KF et al. (1999) A frequent activated smoothened mutation in sporadic basal cell carcinomas. Oncogene 18:833–836PubMedGoogle Scholar
  52. Lantos PL, Vandenberg SR, Kleihues P (1997) Tumors of the nervous sytem. In: Graham DI, Lantos PL (eds) Greenfield’s neuropathology, Arnold, London, pp 583–879Google Scholar
  53. Larocca LM, Capello D, Rinelli A et al. (1998) The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. Blood 92:1011–1019PubMedGoogle Scholar
  54. Lee JH, Sundaram V, Stein DJ, Kinney SE, Stacey DW, Golubic M (1997) Reduced expression of schwannomin/merlin in human sporadic meningiomas. Neurosurgery 40:578–587PubMedGoogle Scholar
  55. Lellouch-Tubiana A, Bourgeois M, Vekemans M, Robain O (1995) Dysembryoplastic neuroepithelial tumors in two children with neurofibromatosis type 1. Acta Neuropathol 90:319–322PubMedGoogle Scholar
  56. Liaw D, Marsh DJ, Li J et al. (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64–67PubMedGoogle Scholar
  57. Lueder GT, Judisch GF, Wen BC (1991) Heritable retinoblastoma and pinealoma. Arch Ophthalmol 109:1707–1709PubMedGoogle Scholar
  58. Martini F, Lazzarin L, Iaccheri L et al. (1998) Simian virus 40 footprints in normal human tissues, brain and bone tumours of different histotypes. Dev Biol Stand 94:55–66PubMedGoogle Scholar
  59. Mason DY, Harris NL (1999) Human lymphoma: clinical implications of the REAL classification. Springer, Berlin Heidelberg New YorkGoogle Scholar
  60. Matsuda M, Yasui K, Nagashima K, Mori W (1987) Origin of the medulloblastoma experimentally induced by human polyomavirus JC. J Natl Cancer Inst 79:585–591PubMedGoogle Scholar
  61. McDonald JD, Daneshvar L, Willert JR, Matsumura K, Waldman F, Co gen PH (1994) Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in meduHoblastoma. Genomies 23:229–232Google Scholar
  62. Meir EG van, Oosterhuis JW, Looijenga LHJ (1998) Genesis and genetics of intracranial germ cell tumors. In: Sawamura Y, Shirato H, Tribolet N de (eds) Intracranial germ cell tumors. Springer, Berlin Heidelberg New York, pp 45–76Google Scholar
  63. Miller DC, Hochberg FH, Harris NL, Gruber ML, Louis DN, Cohen H (1994) Pathology with clinical correlations of primary central nervous system non-Hodgkin’s lymphoma. The Massachusetts General Hospital experience 1958-1989. Cancer 74:1383–1397Google Scholar
  64. Miller JR, Hocking AM, Brown JD, Moon RT (1999) Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways. Oncogene 18:7860–7872PubMedGoogle Scholar
  65. Morgello S (1995) Pathogenesis and classification of primary central nervous system lymphoma: an update. Brain Pathol 5:383–393PubMedGoogle Scholar
  66. Mortimer EA Jr, Lepow ML, Gold E, Robbins FC, Burton GJ, Fraumeni JF Jr (1981) Long-term follow-up of persons inadvertently inoculated with SV 40 as neonates. N Engl J Med 305:1517–1518PubMedGoogle Scholar
  67. Nagashima K, Yasui K, Kimura J, Washizu M, Yamaguchi K, Mori W (1984) Induction of brain tumors by a newly isolated JC virus (Tokyo-1 strain). Am J Pathol 116:455–463PubMedCentralPubMedGoogle Scholar
  68. Numoto RT (1994) Pineal parenchymal tumors: cell differentiation and prognosis. J Cancer Re’s Clin Oncol 120:683–690Google Scholar
  69. Ohgaki H, Eibl RH, Schwab M et al. (1993) Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system. Mol Carcinog 8:74–80PubMedGoogle Scholar
  70. Pencalet P, Sainte-Rose C, Lellouch-Tubiana A et al. (1998) Papillomas and carcinomas of the choroid plexus in children. J Neurosurg 88:521–528PubMedGoogle Scholar
  71. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1997) Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21:1455–1465PubMedGoogle Scholar
  72. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC (1999) “Malignancy” in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85:2046–2056PubMedGoogle Scholar
  73. Petersen I, Hidalgo A, Petersen S et al. (2000) Chromosomal imbalances in brain metastases of solid tumors. Brain Pathol 10:395–401PubMedGoogle Scholar
  74. Pietsch T, Waha A, Koch A et al. (1997) Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Res 57:2085–2088PubMedGoogle Scholar
  75. Platten M, Meyer-Puttlitz B, Blumcke I et al. (1997) A novel splice site associated polymorphism in the tuberous sclerosis 2 (TSC2) gene may predispose to the development of sporadic gangliogliomas. J Neuropathol Exp Neurol 56:806–810PubMedGoogle Scholar
  76. Posner JB (1995) Neurological complications of cancer.Davis, PhiladelphiaGoogle Scholar
  77. Rhodes CH, Glantz MJ, Glantz L et al. (1996) A comparison of polymerase chain re action examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis. Cancer 77:543–548PubMedGoogle Scholar
  78. Rickert CH, Dockhorn-Dworniczak B, Simon R, Paulus W (1999) Chromosomal imbalances in primary lymphomas of the central nervous system. Am J Pathol 155:1445–1451PubMedCentralPubMedGoogle Scholar
  79. Rickert CH, Simon R, Bergmann M, Dockhorn-Dworniczak B, Paulus W (2001) Comparative genomic hybridization in pineal parenchymal tumors. Genes Chromosomes Cancer 30:99–104PubMedGoogle Scholar
  80. Rorke LB, Packer RJ, Biegel JA (1996) Central nervous system a typical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 85:56–65PubMedGoogle Scholar
  81. Ruttledge MH, Xie YG, Han FY et al. (1994) Deletions on chromosome 22 in sporadic meningioma. Genes Chromosomes Cancer 10:122–130PubMedGoogle Scholar
  82. Savla J, Chen TT, Schneider NR, Timmons CF, Delattre O, Tomlinson GE (2000) Mutations of the hSNF5/INI1 gene in renal rhabdoid tumors with second primary brain tumors. J Natl Cancer Inst 92:648–650PubMedGoogle Scholar
  83. Scheurlen WG, Schwabe GC, Joos S, Mollenhauer J, Sorensen N, Kuhl J (1998) Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome. J Clin Oncol 16:2478–2485PubMedGoogle Scholar
  84. Schild SE, Scheithauer BW, Schomberg PJ et al. (1993) Pineal parenchymal tumors. Clinical, pathologic, and therapeutic aspects. Cancer 72:870–880PubMedGoogle Scholar
  85. Schild SE, Scheithauer BW, Haddock MG et al. (1996) Histologically confirmed pineal tumors and other germ cell tumors of the brain. Cancer 78:2564–2571PubMedGoogle Scholar
  86. Schofield D, West DC, Anthony DC, Marshal R, Sklar J (1995) Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas. Am J Pathol 146:472–480PubMedCentralPubMedGoogle Scholar
  87. Segal RA, Goumnerova LC, Kwon YK, Stiles CD, Pomeroy SL (1994) Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci USA 91:12867–12871PubMedCentralPubMedGoogle Scholar
  88. Sevenet N, Lellouch-Tubiana A, Schofield D et al. (1999a) Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum Mol Genet 8:2359–2368PubMedGoogle Scholar
  89. Sevenet N, Sheridan E, Amram D, Schneider P, Handgretinger R, Delattre O (1999b) Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet 65:1342–1348PubMedCentralPubMedGoogle Scholar
  90. Shah K, Nathanson N (1976) Human exposure to SV40: review and comment. Am J Epidemiol 103:1–12PubMedGoogle Scholar
  91. Smyth I, Narang MA, Evans T et al. (1999) Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome Ip32. Hum Mol Genet 8:291–297PubMedGoogle Scholar
  92. Soylemezoglu F, Scheithauer BW, Esteve J, Kleihues P (1997) A typical central neurocytoma. J Neuropathol Exp Neurol 56:551–556PubMedGoogle Scholar
  93. Stein H (2000) [The new WHO classification of malignant lymphoma. After “REAL” a further step on the road to a worldwide consensus]. Pathologe 21:101–105PubMedGoogle Scholar
  94. Taipale J, Chen JK, Cooper MK et al. (2000) Effects of oncogenic mutations in smoothened and patched can be reversed by cyclopamine. Nature 406:1005–1009PubMedGoogle Scholar
  95. TarusCio D, Danesi R, Montaldi A, Cerasoli S, Cenacchi G, Giangaspero F (1997) Nonrandom gain of chromosome 7 in central neurocytoma: a chromosomal analysis and fluorescence in situ hybridization study. Virchows Arch 430:47–51PubMedGoogle Scholar
  96. Tian Q, Frierson HF Jr, Krystal GW, Moskaluk CA (1999) Activating c-kit gene mutations in human germ cell tumors. Am J Pathol 154:1643–1647PubMedCentralPubMedGoogle Scholar
  97. VandenBerg SR (1993) Desmoplastic infantile ganglioglioma and desmoplastic cerebral astrocytoma of infancy. Brain Pathol 3:275–281PubMedGoogle Scholar
  98. Versteege I, Sevenet N, Lange J et al. (1998) Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394:203–206PubMedGoogle Scholar
  99. Weber RG, Bostrom J, Wolter M et al. (1997) Analysis of genomic alterations in benign, a typical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 94:14719–14724PubMedCentralPubMedGoogle Scholar
  100. Weber T, Weber RG, Kaulich K et al. (2000) Characteristic chromosomal imbalances in primary central nervous system lymphomas of the diffuse large B-cell type. Brain Pathol 10:73–84PubMedGoogle Scholar
  101. Wechsler-Reya RJ, Scott MP (1999) Control of neuronal precursor proliferation in the cerebellum by sonic hedgehog. Neuron 22:103–114PubMedGoogle Scholar
  102. Weggen S, B ayer TA, Deimling A von et al. (2000) Low frequency of SV40, JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas. Brain Pathol 10:85–92PubMedGoogle Scholar
  103. Wellenreuther R, Kraus JA, Lenartz D et al. (1995) Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 146:827–832PubMedCentralPubMedGoogle Scholar
  104. Williams BO, Remington L, Albert DM, Mukai S, Bronson RT, Jacks T (1994) Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet 7:480–484PubMedGoogle Scholar
  105. Wodarz A, Nusse R (1998) Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14:59–88PubMedGoogle Scholar
  106. Zhang SJ, Endo S, Ichikawa T, Washiyama K, Kumanishi T (1998) Frequent deletion and 5’ CpG island methylation of the p16 gene in primary malignant lymphoma of the brain. Cancer Res 58:1231–1237PubMedGoogle Scholar
  107. Zhu JJ, Leon SP, Folkerth RD, Guo SZ, Wu JK, Black PM (1997) Evidence for clonal origin of neoplastic neuronal and glial cells in gangliogliomas. Am J Pathol 151:565–571PubMedCentralPubMedGoogle Scholar
  108. Zu Rhein GM, Varakis JN (1979) Perinatal induction of medulloblastomas in Syrian golden hamsters by a human polyoma virus OC). Natl Cancer Inst Monogr 205–208Google Scholar
  109. Zurawel RH, Chiappa SA, Allen C, Raffel C (1998) Sporadic medulloblastomas contain oncogenic beta-catenin mutations. Cancer Res 58:896–899PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • Torsten Pietsch

There are no affiliations available

Personalised recommendations